Cleared Traditional

K033617 - EECP THERAPY SYSTEM MODEL TS4 WITH/WITHOUT PLUSE OXIMETRY

K033617 is an FDA 510(k) clearance for EECP THERAPY SYSTEM MODEL TS4 WITH/WITH..., manufactured by Vasomedical, Inc.. The device is a Class 2 Cardiovascular device with product code DRN cleared through the Traditional 510(k) pathway after a 104-day FDA review.

K033617 · Vasomedical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2004
Decision
104d
Days
Class 2
Risk

K033617 is an FDA 510(k) clearance for the EECP THERAPY SYSTEM MODEL TS4 WITH/WITHOUT PLUSE OXIMETRY. Classified as Device, Counter-pulsating, External (product code DRN), Class II - Special Controls.

Submitted by Vasomedical, Inc. (Westbury, US). The FDA issued a Cleared decision on March 1, 2004 after a review of 104 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5225 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Vasomedical, Inc. devices

FDA 510(k) Submission Details - K033617

510(k) Number K033617 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 18, 2003
Decision Date March 01, 2004
Days to Decision 104 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
21d faster than avg
Panel avg: 125d · This submission: 104d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRN Device Classification - Class 2, Special Controls

Product Code DRN Device, Counter-pulsating, External
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5225
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRN Device, Counter-pulsating, External

All 11
Devices cleared under the same product code (DRN) and FDA review panel - the closest regulatory comparables to K033617.
EXTERNAL COUNTERPULSATION DEVICE WITH SP02 MORNITORING
K130439 · Chongqing Psk Sci-Tech Development Co., Ltd. · Dec 2013
CARDIASSIST COUNTER PULSATION SYSTEM SERIES 4000/5000
K050172 · Cardiomedics, Inc. · Mar 2005
ACS MODEL NCP-2
K042413 · Applied Cardiac Systems · Dec 2004
NICORE MODEL ESP -1
K980937 · Nicore Equipment & Leasing, Inc. · Sep 2000
THE CIRCULATOR BOOT
K971026 · Circulator Boot Corp. · Aug 1997